These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
393 related articles for article (PubMed ID: 37968670)
1. Selection of M7G-related lncRNAs in kidney renal clear cell carcinoma and their putative diagnostic and prognostic role. Zhong S; Chen S; Lin H; Luo Y; He J BMC Urol; 2023 Nov; 23(1):186. PubMed ID: 37968670 [TBL] [Abstract][Full Text] [Related]
2. The clinical significance, immune infiltration, and tumor mutational burden of angiogenesis-associated lncRNAs in kidney renal clear cell carcinoma. Zhang W; Liu Z; Wang J; Geng B; Hou W; Zhao E; Li X Front Immunol; 2022; 13():934387. PubMed ID: 35958561 [TBL] [Abstract][Full Text] [Related]
3. Functional Long Noncoding RNAs (lncRNAs) in Clear Cell Kidney Carcinoma Revealed by Reconstruction and Comprehensive Analysis of the lncRNA-miRNA-mRNA Regulatory Network. Zhu H; Lu J; Zhao H; Chen Z; Cui Q; Lin Z; Wang X; Wang J; Dong H; Wang S; Tan J Med Sci Monit; 2018 Nov; 24():8250-8263. PubMed ID: 30444862 [TBL] [Abstract][Full Text] [Related]
4. Comprehensive Analysis of N6-Methyladenosine-Related IncRNAs Prognostic Signature and the Associated Immune Infiltrates in Kidney Renal Clear Cell Carcinoma. Chen X; Wang L; Tu J; Pan X; Li Y; Yin H; Wang M; Yuan X Crit Rev Eukaryot Gene Expr; 2022; 32(1):79-98. PubMed ID: 35377983 [TBL] [Abstract][Full Text] [Related]
5. Clinicopathological and Prognostic Value of Necroptosis-Associated lncRNA Model in Patients with Kidney Renal Clear Cell Carcinoma. Gu J; He Z; Huang Y; Luan T; Chen Z; Wang J; Ding M Dis Markers; 2022; 2022():5204831. PubMed ID: 35664432 [TBL] [Abstract][Full Text] [Related]
6. M7G-Related lncRNAs predict prognosis and regulate the immune microenvironment in lung squamous cell carcinoma. Pan J; Huang Z; Lin H; Cheng W; Lai J; Li J BMC Cancer; 2022 Nov; 22(1):1132. PubMed ID: 36333719 [TBL] [Abstract][Full Text] [Related]
7. Immune associated LncRNAs identify novel prognostic subtypes of renal clear cell carcinoma. Khadirnaikar S; Kumar P; Pandi SN; Malik R; Dhanasekaran SM; Shukla SK Mol Carcinog; 2019 Apr; 58(4):544-553. PubMed ID: 30520148 [TBL] [Abstract][Full Text] [Related]
8. Prognosis Signature of Cuprotosis-Related lncRNAs Associated with Kidney Renal Clear Cell Carcinoma. Gao Y; Jia Z Genet Res (Camb); 2022; 2022():6004852. PubMed ID: 36474620 [TBL] [Abstract][Full Text] [Related]
9. Identification and Validation of Two Novel Prognostic lncRNAs in Kidney Renal Clear Cell Carcinoma. Song J; Peng J; Zhu C; Bai G; Liu Y; Zhu J; Liu J Cell Physiol Biochem; 2018; 48(6):2549-2562. PubMed ID: 30121668 [TBL] [Abstract][Full Text] [Related]
10. Disulfidptosis-Related LncRNA Signatures for Prognostic Prediction in Kidney Renal Clear Cell Carcinoma. Feng K; Zhou S; Sheng Y; Lu K; Li C; Liu W; Kong H; Liu H; Mu Y; Zhang L; Zhang Q; Wang J Clin Genitourin Cancer; 2024 Aug; 22(4):102095. PubMed ID: 38833825 [TBL] [Abstract][Full Text] [Related]
11. Computational construction of TME-related lncRNAs signature for predicting prognosis and immunotherapy response in clear cell renal cell carcinoma. Zhou L; Fang H; Guo F; Yin M; Long H; Weng G J Clin Lab Anal; 2022 Aug; 36(8):e24582. PubMed ID: 35808868 [TBL] [Abstract][Full Text] [Related]
12. Disulfidptosis-associated LncRNA signature predicts prognosis and immune response in kidney renal clear cell carcinoma. Xu K; Li D; Ji K; Zhang Y; Zhang M; Zhou H; Hou X; Jiang J; Zhang Z; Dai H; Sun H Biol Direct; 2024 Aug; 19(1):71. PubMed ID: 39175011 [TBL] [Abstract][Full Text] [Related]
13. Construction and validation of an autophagy-related long noncoding RNA signature for prognosis prediction in kidney renal clear cell carcinoma patients. Yu J; Mao W; Xu B; Chen M Cancer Med; 2021 Apr; 10(7):2359-2369. PubMed ID: 33650306 [TBL] [Abstract][Full Text] [Related]
14. Bioinformatics analysis of markers based on m Liu L; Zhuang M; Tu XH; Li CC; Liu HH; Wang J Cell Biol Int; 2023 Jan; 47(1):260-272. PubMed ID: 36200528 [TBL] [Abstract][Full Text] [Related]
15. CD72, a new immune checkpoint molecule, is a novel prognostic biomarker for kidney renal clear cell carcinoma. Tian L; Wang Y; Zhang Z; Feng X; Xiao F; Zong M Eur J Med Res; 2023 Nov; 28(1):531. PubMed ID: 37980541 [TBL] [Abstract][Full Text] [Related]
16. Identification and Validation of Cuproptosis-Related LncRNA Signatures in the Prognosis and Immunotherapy of Clear Cell Renal Cell Carcinoma Using Machine Learning. Bai Z; Lu J; Chen A; Zheng X; Wu M; Tan Z; Xie J Biomolecules; 2022 Dec; 12(12):. PubMed ID: 36551318 [TBL] [Abstract][Full Text] [Related]
17. A Novel M7G-Related MicroRNAs Risk Signature Predicts the Prognosis and Tumor Microenvironment of Kidney Renal Clear Cell Carcinoma. Hong P; Du H; Tong M; Cao Q; Hu D; Ma J; Jin Y; Li Z; Huang W; Tong G Front Genet; 2022; 13():922358. PubMed ID: 35812727 [No Abstract] [Full Text] [Related]
18. Construction and validation of a model based on immunogenic cell death-associated lncRNAs to predict prognosis and direct therapy for kidney renal clear cell carcinoma. Cai C; Shu K; Chen W; Ding J; Guo Z; Wei Y; Zhang W Aging (Albany NY); 2023 Jun; 15(12):5304-5338. PubMed ID: 37379129 [TBL] [Abstract][Full Text] [Related]
19. Comprehensive analysis of MFN2 as a prognostic biomarker associated with immune cell infiltration in renal clear cell carcinoma. Cheng L; Wang Z; Nie L; Yang C; Huang H; Lin J; Zhuo D Int Immunopharmacol; 2022 Oct; 111():109169. PubMed ID: 36007389 [TBL] [Abstract][Full Text] [Related]
20. Construction and validation of a prognostic signature for mucinous colonic adenocarcinoma based on N7-methylguanosine-related long non-coding RNAs. Gao Y; Ren J; Chen K; Guan G J Gastrointest Oncol; 2024 Feb; 15(1):203-219. PubMed ID: 38482248 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]